NEW YORK (TheStreet) -- Shares of McKesson Corp. (MCK) are up 3.32% to $180.01 on heavy volume after the company reported its fiscal fourth quarter earnings in after-market trading yesterday, beating analysts' estimates for earnings and revenue.
In the quarter, the healthcare services and information technology company reported earnings of $2.55 a share, beating the Capital IQ Consensus Estimate of $2.40 a share by 15 cents.
Revenue was up 24.4% from the year-ago quarter to $38.1 billion. Analysts expected revenue of $35.9 billion for the quarter.
John H. Hammergren, chairman and CEO provided a fiscal year 2105 outlook:
"Our Fiscal 2015 guidance reflects solid growth across our broad portfolio of businesses and McKesson's share of the results of Celesio. McKesson expects adjusted earnings per diluted share between $10.40 and $10.80 for the fiscal year ending March 31, 2015," he said.
TheStreet Ratings team rates MCKESSON CORP as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate MCKESSON CORP (MCK) a BUY. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income."